1. Weinberg, R.A. The retinoblastoma protein and cell cycle control. Cell 81, 323–330 (1995).
2. He, J. et al. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res. 54, 5804–5807 (1994).
3. Ueki, K. et al. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res. 56, 150–153 (1996).
4. Jen, J. et al. Deletion of p16 and p15 genes in brain tumors. Cancer Res. 54, 6353–6358 (1994).
5. Schmidt, E.E., Ichimura, K., Reifenberger, G. & Collins, V.P. CDKN2/p16/MTSI/ gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res. 54, 6321–6324 (1994).